Institutional Ownership Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX). We have compiled data on the 246 institutions that hold shares in the stock, with a total of 56.4 Million shares, which have been reported (via 13F filing form) to have a value of $2.31 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
5,861,006
shares
|
$241 Million
1.32% of portfolio
|
Q3 2024
Added 0.35%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,758,112
shares
|
$237 Million
0.0% of portfolio
|
Q2 2024
Added 3.39%
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
5,426,112
shares
|
$223 Million
3.89% of portfolio
|
Q3 2024
Added 2.64%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
4,216,081
shares
|
$173 Million
0.0% of portfolio
|
Q3 2024
Added 29.99%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
3,183,542
shares
|
$131 Million
0.01% of portfolio
|
Q3 2024
Added 52.88%
|
|
Johnson & Johnson
New Brunswick, NJ |
Nov 13, 2024 Q3 2024 |
2,449,183
shares
|
$101 Million
35.09% of portfolio
|
Q3 2021
New holding
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,850,167
shares
|
$76.1 Million
2.64% of portfolio
|
Q3 2024
Reduced 44.26%
|
|
Jefferies Financial Group Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,814,696
shares
|
$74.6 Million
0.6% of portfolio
|
Q3 2024
Reduced 11.07%
|
|
Pacer Advisors, Inc.
Malvern, PA |
Nov 12, 2024 Q3 2024 |
1,734,090
shares
|
$71.3 Million
0.19% of portfolio
|
Q3 2024
Added 405061.22%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,374,697
shares
|
$56.5 Million
0.01% of portfolio
|
Q3 2024
Added 0.26%
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,374,563
shares
|
$56.5 Million
1.61% of portfolio
|
Q3 2024
Added 8.34%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,309,467
shares
|
$53.8 Million
0.01% of portfolio
|
Q3 2024
Added 8.26%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,200,891
shares
|
$49.4 Million
0.1% of portfolio
|
Q3 2024
Reduced 40.0%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
981,295
shares
|
$40.3 Million
7.18% of portfolio
|
Q3 2024
Reduced 38.82%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
821,856
shares
|
$33.8 Million
0.01% of portfolio
|
Q3 2024
Added 39.12%
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
653,152
shares
|
$26.9 Million
0.01% of portfolio
|
Q3 2024
Added 638.58%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
628,623
shares
|
$25.8 Million
0.0% of portfolio
|
Q3 2024
Added 82.05%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
580,089
shares
|
$23.8 Million
0.0% of portfolio
|
Q3 2024
Added 14.09%
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
574,775
shares
|
$23.6 Million
0.02% of portfolio
|
Q3 2024
Added 2004.55%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
565,503
shares
|
$23.2 Million
0.0% of portfolio
|
Q3 2024
Added 7.58%
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
502,985
shares
|
$20.7 Million
0.0% of portfolio
|
Q3 2024
Added 33.56%
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
466,518
shares
|
$19.2 Million
0.19% of portfolio
|
Q3 2024
Reduced 43.26%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2024 Q3 2024 |
456,369
shares
|
$18.8 Million
1.68% of portfolio
|
Q3 2024
Reduced 42.95%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
445,352
shares
|
$18.3 Million
0.2% of portfolio
|
Q3 2024
Reduced 20.02%
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
445,204
shares
|
$18.3 Million
1.58% of portfolio
|
Q3 2024
Reduced 11.99%
|